Dr. P. Vaishnavi Reddy

• Full Name: Dr P. Vaishanvi
• Designation : Consultant
• Specialty / Division : Radiation Oncology — Head and neck, Urology, CNS.
• Educational Qualification: MBBS, DNB (Radiation Oncology), PDCR
• Years of Experience (total): 8 years
• Medical Registration / License No.: 67531
• Email: drpvaishnavi@basavatarakam.org
• Contact Number: 8977410718, EXT: 2327

Memberships:
She is a member of the Association of Radiation Oncologists of India.

Publications: 

1. P Vaishnavi, Syed Fathima. Small cell GBM- Case report with review of literature. IP Indian Journal of Neurosciences (01/11/24). https://doi.org/10.18231/j.ijn.2024.049

1. Akkineni, N.P., Kavikondala, M., Penumarti, S.V., P. Vaishnavi et al. Practical Challenges and Implementation Considerations for Induction Chemotherapy Followed by Concurrent Chemoradiotherapy in Locally Advanced Cervical Cancer: Experience from a Tertiary Cancer Center in India. Indian J Gynecol Oncolog 23, 112 (2025). https://doi.org/10.1007/s40944-025-01043-8

 

1. A comparative study of dose distribution in the Hippocampus in high grade glioma irradiation using Linac based IMRT and VMAT, Aroicon 2016, Poster presentation.

 

1. A prospective comparative study to evaluate the effect of hypo fractionation and conventional fractionation in post mastectomy breast cancer patients. NCCN 2018 Orlando. Poster presentation.

1. Radiological response with induction chemotherapy in locally advanced cancer cervix- A single institute experience.  AROICON 2024, Oral presentation

1. Sinonasal Teratocarcinosarcoma- A rare entity managed by trans nasal surgical excision followed by adjuvant chemoradiation. AROICON 2024, Oral presentation.

 

1. Prospective study on the effect of comorbidities on acute gastrointestinal and genitourinary toxicities in patients with cancer cervix treated with 3DCRT, IMRT and VMAT. Poster presentation at AROICON 2016.

 

1. IMRT VS 3DCRT in postoperative gynaecological malignancies.  A comparative study to assess acute toxicities. Poster presentation Cancer CI 2015.